You are using an outdated browser. Please upgrade your browser to improve your experience.

You are here

Depression

The PMC reviewed relevant performance measures and makes the following recommendations.

Printable version of the recommendations.
Addendum to printable version of the recommendations.

ACP does not support this measure.

ID# PQRS 106
[Removed from PQRS Jan 2015, Previously NQF 0103]

More Information

Adult Major Depressive Disorder (MDD): Comprehensive Depression Evaluation: Diagnosis and Severity

Percentage of patients aged 18 years and older with a diagnosis or recurrent episode of major depressive disorder (MDD) with evidence that they met the DSM-IV criteria for MDD AND for whom there is an assessment of depression severity during the visit in which a new diagnosis or recurrent episode was identified.
Date Reviewed: April 27, 2015

ACP does not support this measure.

ID# NQF 0104
ID# PQRS 107

More Information

Adult major Depressive Disorder (MDD): Suicide Risk Assessment

Percentage of patients aged 18 years and older with a new diagnosis or recurrent episode of major depressive disorder (MDD) with a suicide risk assessment completed during the visit in which a new diagnosis or recurrent episode was identfied.
Date Reviewed: April 27, 2015

ACP does not support this measure.

ID# NQF 0105
ID# PQRS 9

More Information

Antidepressant Medication Management

The percentage of members 18 years of age and older with a diagnosis of major depression and were newly treated with antidepressant medication, and who remained on an antidepressant medication treatment. Two rates are reported: a) Effective Acute Phase Treatment. The percentage of newly diagnosed and treated members who remained on an antidepressant medication for at least 84 days (12 weeks). b) Effective Continuation Phase Treatment. The percentage of newly diagnosed and treated members who remained on an antidepressant medication for at least 180 days (6 months).
Date Reviewed: April 27, 2015

ACP does not support this measure.

ID# NQF 0418
ID# PQRS 134

More Information

Preventive Care and Screening: Screening for Clinical Depression and Follow-Up Plan

Percentage of patients aged 12 years and older screened for clinical depression using an age appropriate standardized tool AND follow-up plan documented.
Date Reviewed: April 27, 2015

ACP does not support this measure.

ID# NQF 0710

More Information

Depression Remission at Twelve Months
Adult patients age 18 and older with major depression or dysthymia and an initial PHQ-9 score > 9 who demonstrate remission at twelve months defined as a PHQ-9 score less than 5. This measure applies to both patients with newly diagnosed and existing depression whose current PHQ-9 score indicates a need for treatment. This measure additionally promotes ongoing contact between the patient and provider as patients who do not have a follow-up PHQ-9 score at twelve months (+/- 30 days) are also included in the denominator
Date Reviewed: November 7, 2015

ACP supports this measure.

ID# NQF 0712

More Information

Depression Utilization of the PHQ-9 Tool

Adult patients age 18 and older with the diagnosis of major depression or dysthymia who have a PHQ-9 tool administered at least once during the four month measurement period. The Patient Health Questionnaire (PHQ-9) tool is a widely accepted, standardized tool that is completed by the patient, ideally at each visit, and utilized by the provider to monitor treatment progress
Date Reviewed: November 7, 2015

ACP does not support this measure.

ID# NQF 1885

More Information

Depression Response at Twelve Months, Progress Towards Remission

Adult patients age 18 and older with major depression or dysthymia and an initial PHQ-9 score > 9 who demonstrate a response to treatment at twelve months defined as a PHQ-9 score that is reduced by 50% or greater from the initial PHQ-9 score. This measure applies to both patients with newly diagnosed and existing depression identified during the defined measurement period whose current PHQ-9 score indicates a need for treatment.
Date Reviewed: November 7, 2015